Methods of treatment of partial onset seizures using eslicarbazepine acetate
AssigneeBial - Portela & Ca, S.A.
InventorsJosé Luis de Almeida, Patrício Manuel Vieira Araújo Soares da Silva
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
Claims30
A method for treating a patient with partial-onset seizures, comprising:
- administering once-daily to a patient in need thereof a pharmaceutical composition consisting essentially of eslicarbazepine acetate, wherein the once-daily administration is pharmacologically effective to treat partial-onset seizures in the patient, and wherein the patient is a human.
A method for treating a patient with partial-onset seizures, comprising exposing the patient in need thereof to a higher rate of exposure to eslicarbazepine, in terms of Cmax, wherein the rate of exposure is increased by providing the patient a once-daily amount of eslicarbazepine, rather than providing the same total amount of eslicarbazepine divided twice-daily.
Dependencies are inferred from the claim text.